Analysts issued a wave of downgrades on Saturday. Three mid-to-large-cap stocks drew the sharpest cuts.
Johnson Controls International was downgraded, with the consensus target slipping to $162. The building-tech giant carries an $89B market cap. Short interest sits at just 1.6% of free float — bears are not the story here. The downgrade reflects analyst caution on industrial fundamentals rather than short-side pressure.
Bristol-Myers Squibb also took a hit. Analysts cut the rating and trimmed the average target to $64.91. The pharma heavyweight has a $133B market cap. SI sits at 2.4% of free float. Sell-side counts now show 18 holds against just 8 sells — a crowded fence. Any negative pipeline news could sharpen that split quickly.
Zebra Technologies was downgraded too. Target held at $332. Short interest is higher at 6.9% of free float. Availability of shares to borrow is still ample at 691%. That suggests the downgrade hasn't yet triggered a big short-selling rush.
On the positive side, Amazon saw its consensus target nudge up to $321.95. Analysts overwhelmingly back the stock — 59 buys versus just 3 holds. Hasbro and AbbVie also received modest target upgrades from their respective analyst pools.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
